Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Metastatic Colorectal Carcinoma (mCRC) · Colorectal Cancer (CRC) · Adenomatous Polyposis Coli (APC) Gene Mutation · Catenin Beta-1 (CTNNB1) Gene Mutation
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Clinical Trials Nurse Navigator, Scottsdale, Arizona, United States
Contact: Study coordinator (Clinical Trials Nurse Navigator) · clinicaltrials@honorhealth.com · 833-354-6667Contact: Principal Investigator (Carol Carol Guarnieri, RN, MSN, FNP-BC)